norethindrone has been researched along with Ovarian Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (65.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A; Sharma, I | 1 |
| Dinulescu, DM; Gilliam, ML; Gordon, IO; Jagadeeswaran, S; Kim, HH; Krausz, TN; Lee, WS; Lengyel, E; Mui, KL; Romero, IL | 1 |
| Koskela-Niska, V; Lyytinen, H; Pukkala, E; Riska, A; Ylikorkala, O | 1 |
| BORY, R; CAPLIER, P | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Godoy-Tundidor, S; Ho, SM; Mukherjee, K; Syed, V | 1 |
| Iglesias, R; Lipschutz, A; Panasevich, VI; Salinas, S | 1 |
| Quinn, MA | 1 |
| Behling, H; Brückmann, D; Kademann, J; Krafft, W; Preibsch, W; Schirmer, A; Steuckart, R | 1 |
| Baze, W; Brewer, M; Follen, M; Hill, L; Khan-Dawood, F; Satterfield, W; Utzinger, U; Wharton, JT | 1 |
| Adamian, LV; Strizhakov, AN; Zheleznov, BI | 1 |
| Carey, HM | 1 |
| Shchurko, NI; Zaporozhan, VN | 1 |
| Brumsted, JR; Chapitis, J; Gibson, M; Riddick, D | 1 |
| Baird, PJ; Crandon, AJ; Eastman, CJ; Fay, R; Hudson, CN; Toppila, M; Tyler, JP | 1 |
| Guérin, MT; Guérin, RA | 1 |
| Andersen, RN; Coleman, SA; Fish, SA; Givens, JR; Kerber, IJ; Wiser, WL | 1 |
| Fuller, ME | 1 |
| Snaith, L | 1 |
1 review(s) available for norethindrone and Ovarian Neoplasms
| Article | Year |
|---|---|
[GYNECOLOGY].
Topics: Abortion, Threatened; Ascites; Capillary Resistance; Endometriosis; Estriol; Estrogens; Female; Genital Neoplasms, Female; Glycoside Hydrolases; Gold Isotopes; Gonadal Steroid Hormones; Gonadotropins; Gynecology; Humans; Menopause; Neoplasms; Norethindrone; Norethynodrel; Ovarian Neoplasms; Polycystic Ovary Syndrome; Pregnancy; Pregnanediol; Progesterone; Progestins; Uterine Prolapse | 1963 |
19 other study(ies) available for norethindrone and Ovarian Neoplasms
| Article | Year |
|---|---|
In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Cyclooxygenase 2; Female; Humans; Membrane Proteins; Norethindrone; Ovarian Neoplasms; Pregnancy; Progesterone Congeners; Progestins; Reactive Oxygen Species; Receptors, Progesterone; Vascular Endothelial Growth Factor A | 2023 |
Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.
Topics: Animals; Apoptosis; Blotting, Western; Contraceptives, Oral, Synthetic; Disease Models, Animal; Estrogens; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Immunoenzyme Techniques; Integrases; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Neoplasm Invasiveness; Norethindrone; Ovarian Neoplasms; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; Tumor Cells, Cultured | 2009 |
Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
Topics: Aged; Aged, 80 and over; Confidence Intervals; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Postmenopause; Progestins; Risk Assessment; Time Factors | 2013 |
Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors?
Topics: Analysis of Variance; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Female; Fibroblast Growth Factors; Humans; In Vitro Techniques; Insulin-Like Growth Factor Binding Proteins; Medroxyprogesterone Acetate; Norethindrone; Ovarian Neoplasms; Progestins; Protective Agents | 2006 |
Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Female; GPI-Linked Proteins; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Progesterone; Progestins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor, Member 10c; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors | 2007 |
Ovarian tumours and other ovarian changes induced in mice by two 19-nor-contraceptives.
Topics: Animals; Contraceptives, Oral; Female; Mice; Neoplasms, Experimental; Norethindrone; Norethynodrel; Ovarian Neoplasms | 1967 |
Is endocrine status relevant to treatment planning in patients with gynaecological cancer?
Topics: Carcinoma; Female; Humans; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Uterine Neoplasms | 1984 |
[Problems in the therapy of ovarian carcinoma with gestagen-acting hormones].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Neoplasm Staging; Norethindrone; Ovarian Neoplasms | 1983 |
Rhesus macaque model for ovarian cancer chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Biopsy; Contraceptives, Oral, Combined; Disease Models, Animal; Drug Combinations; Female; Fenretinide; Humans; Macaca mulatta; Mestranol; Norethindrone; Ovarian Neoplasms; Ovary; Spectrometry, Fluorescence | 2001 |
[Clinico-morphological characteristics of endometriosis of different localization during treatment with synthetic progestins].
Topics: Adult; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Humans; Mestranol; Norethindrone; Norethynodrel; Ovarian Neoplasms; Progesterone Congeners; Uterine Neoplasms | 1979 |
Dysmenorrhoea.
Topics: Adolescent; Adult; Analgesics; Drug Combinations; Drug Therapy, Combination; Dysmenorrhea; Endometriosis; Endometrium; Ethinyl Estradiol; Female; Humans; Menstruation; Norethindrone; Norethynodrel; Ovarian Neoplasms; Prostaglandins E; Prostaglandins F; Uterine Neoplasms | 1975 |
[The role of the system of proteolytic enzymes and their inhibitors in the pathogenesis of ovarian tumors in Wistar rats and the possibilities for correcting the disorders detected].
Topics: Animals; Antineoplastic Agents; Aprotinin; Chlormadinone Acetate; Contraceptives, Oral, Combined; Drug Combinations; Drug Screening Assays, Antitumor; Female; Granulosa Cell Tumor; Neoplasm Transplantation; Norethindrone; Ovarian Neoplasms; Ovariectomy; Peptide Hydrolases; Protease Inhibitors; Rats; Rats, Inbred Strains; Thecoma | 1990 |
Norethindrone inhibition of testosterone secretion by an ovarian Sertoli-Leydig cell tumor.
Topics: Adult; Female; Humans; Leydig Cell Tumor; Norethindrone; Ovarian Neoplasms; Sertoli Cell Tumor; Testosterone | 1987 |
Steroid receptors in human ovarian malignancy. A review of four years tissue collection.
Topics: Adult; Estrogens; Female; Hormones; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone | 1986 |
Hormones in advanced cancer.
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adrenalectomy; Androgens; Androstanols; Breast Neoplasms; Estrogens; Female; Hirsutism; Hormones; Humans; Hypercalcemia; Hypertension; Hypophysectomy; Male; Nandrolone; Norethindrone; Ovarian Neoplasms; Progesterone; Prostatic Neoplasms; Thyroid Hormones; Thyroid Neoplasms; Urogenital Neoplasms; Uterine Neoplasms; Vasopressins | 1971 |
[Use of progestational hormones in the treatment of advanced stages of breast and gynaecologic carcinoma].
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Norethindrone; Ovarian Neoplasms; Pleural Neoplasms; Progestins; Skin Neoplasms; Uterine Neoplasms | 1969 |
Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
Topics: 17-Ketosteroids; Acanthosis Nigricans; Adolescent; Adrenocorticotropic Hormone; Androstenedione; Chorionic Gonadotropin; Dexamethasone; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Mestranol; Norethindrone; Ovarian Neoplasms; Polycystic Ovary Syndrome; Testosterone; Thecoma | 1974 |
Oral contraceptive therapy for differentiating ovarian cysts.
Topics: Adult; Contraceptives, Oral; Cystadenoma; Diagnosis, Differential; Endometriosis; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Mestranol; Norethindrone; Norethynodrel; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Pituitary Gland | 1971 |
The treatment of endometriosis by oral progestogens.
Topics: Adult; Dyspareunia; Embryo Implantation; Endometriosis; Endometrium; Estrogens; Female; Granulosa Cell Tumor; Humans; Hysterectomy; Laparotomy; Norethindrone; Ovarian Neoplasms; Progestins | 1968 |